Just , experts have focused on the drug, a innovative compound that targets several insulin systems involved in controlling blood glucose . Unlike traditional diabetes therapies, it shows substantial progress in not only glucose regulation and weight loss . Preliminary patient data suggest that may offer a substantial advance in the care . Unders